A
Amneal Intermediate Inc
NASDAQ:AMRX
Amneal Intermediate Inc
NASDAQ:AMRX
Price:
13.19
USD
-0.83%
Market Cap:
$4.1B
Relative Value
The Relative Value of one AMRX stock under the Base Case scenario is hidden USD. Compared to the current market price of 13.19 USD, Amneal Intermediate Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AMRX Relative Value
HIDDEN
Multiples Across Competitors
AMRX Competitors Multiples
Amneal Intermediate Inc Competitors
Amneal Intermediate Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Amneal Intermediate Inc
NASDAQ:AMRX
|
4.1B USD | 1.4 | 699.4 | 10.9 | 18.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919B USD | 14.1 | 44.4 | 30 | 32 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
569B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.3B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
240.6B CHF | 5.5 | 22.1 | 13.7 | 17.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.1B GBP | 5.3 | 30.2 | 16.7 | 23.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.5B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.3B USD | 2.4 | 19.4 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
